Modification of avian pathogenic Escherichia coli χ7122 lipopolysaccharide increases accessibility to glycoconjugate antigens

Modification of avian pathogenic Escherichia coli χ7122 lipopolysaccharide increases accessibility to glycoconjugate antigens

Abstract Background Worldwide, an estimated 70.7 billion broilers were produced in 2020. With the reduction in use of prophylactic antibiotics as a result of consumer pressure and regulatory oversight alternative approaches, such as vaccination, are required to control bacterial infections. A potent...

Full description

Bibliographic Details
Main Authors: Alexander A. Smith, Ricardo Corona-Torres, Rachel E. Hewitt, Mark P. Stevens, Andrew J. Grant, the Glycoengineering of Veterinary Vaccines Consortium
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Microbial Cell Factories
Subjects:
Protein glycan coupling technology
Vaccine
Poultry
Glycoconjugate lipopolysaccharide
Online Access:https://doi.org/10.1186/s12934-022-01903-4

Internet

https://doi.org/10.1186/s12934-022-01903-4

Similar Items